Trial Profile
An Open Pilot Study to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Pick's Disease/Frontotemporal Dementia /Pick Complex
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2008
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Dementia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 30 Mar 2007 New trial record.